LFC Stock Overview
Lifecare AS engages in the research and development of medical sensors for health monitoring in Norway.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Lifecare AS Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr0.23 |
| 52 Week High | kr0.46 |
| 52 Week Low | kr0.097 |
| Beta | -0.060 |
| 1 Month Change | -32.21% |
| 3 Month Change | -22.65% |
| 1 Year Change | 63.48% |
| 3 Year Change | -15.10% |
| 5 Year Change | n/a |
| Change since IPO | -22.91% |
Recent News & Updates
Recent updates
Shareholder Returns
| LFC | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 4.3% | -0.5% | 2.0% |
| 1Y | 63.5% | -6.1% | 5.9% |
Return vs Industry: LFC exceeded the German Medical Equipment industry which returned -4.6% over the past year.
Return vs Market: LFC exceeded the German Market which returned 6% over the past year.
Price Volatility
| LFC volatility | |
|---|---|
| LFC Average Weekly Movement | 24.0% |
| Medical Equipment Industry Average Movement | 4.6% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 10.3% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: LFC's share price has been volatile over the past 3 months.
Volatility Over Time: LFC's weekly volatility (24%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 32 | Joacim Holter | www.lifecare.no |
Lifecare AS engages in the research and development of medical sensors for health monitoring in Norway. The company develops Sencell, a micro sensor for monitoring glucose levels in patients with diabetes. It manufactures and develops nanostrain biosensors for measuring pressure and temperature in live tissue.
Lifecare AS Fundamentals Summary
| LFC fundamental statistics | |
|---|---|
| Market cap | €30.54m |
| Earnings (TTM) | -€3.02m |
| Revenue (TTM) | €1.12m |
27.3x
P/S Ratio-10.1x
P/E RatioIs LFC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LFC income statement (TTM) | |
|---|---|
| Revenue | kr13.09m |
| Cost of Revenue | kr0 |
| Gross Profit | kr13.09m |
| Other Expenses | kr48.34m |
| Earnings | -kr35.26m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Aug 27, 2024
| Earnings per share (EPS) | -0.26 |
| Gross Margin | 100.00% |
| Net Profit Margin | -269.43% |
| Debt/Equity Ratio | 4.4% |
How did LFC perform over the long term?
See historical performance and comparison